These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8883707)

  • 1. 123I-MIBG myocardial imaging in hypertensive patients: abnormality progresses with left ventricular hypertrophy.
    Mitani I; Sumita S; Takahashi N; Ochiai H; Ishii M
    Ann Nucl Med; 1996 Aug; 10(3):315-21. PubMed ID: 8883707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of [123I]MIBG to assess cardiac adrenergic innervation: experience in hypertensive cardiopathy and left ventricular aneurysms.
    Giordano A; Calcagni ML; Rufini V; Colivicchi F; Melina D; Melina G; Pristipino C; Nori S; Trani C; Santarelli P
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):44-8. PubMed ID: 9002748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct evidence of impaired cardiac sympathetic innervation in essential hypertensive patients with left ventricular hypertrophy.
    Kuwahara T; Hamada M; Hiwada K
    J Nucl Med; 1998 Sep; 39(9):1486-91. PubMed ID: 9744329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the relationship between regression of hypertensive cardiac hypertrophy and improvement of cardiac sympathetic nervous dysfunction using iodine-123 metaiodobenzylguanidine myocardial imaging.
    Morimoto S; Terada K; Keira N; Satoda M; Inoue K; Tatsukawa H; Katoh S; Ida K; Sugihara H; Takeda K; Nakagawa M
    Eur J Nucl Med; 1996 Jul; 23(7):756-61. PubMed ID: 8662113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy. An analysis using 123I-meta-iodobenzylguanidine scintigraphy.
    Wichter T; Hindricks G; Lerch H; Bartenstein P; Borggrefe M; Schober O; Breithardt G
    Circulation; 1994 Feb; 89(2):667-83. PubMed ID: 8313555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial imaging with 123I-metaiodobenzylguanidine in essential hypertension and renovascular hypertension.
    Ohya Y; Sasaki M; Fujishima S; Kagiyama S; Onaka U; Kaseda S; Ohmori S; Kuwabara Y; Abe I; Fujishima M
    Clin Exp Hypertens; 2001 May; 23(4):293-304. PubMed ID: 11349821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective cardiac neuroadrenergic abnormalities in hypertensive patients with left ventricular hypertrophy.
    Giordano A; Melina G; Calcagni ML; Schinzari F; Cirillo F; Mettimano M; Cardillo C; Melina D
    Arch Med Res; 2007 Jul; 38(5):512-8. PubMed ID: 17560456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cardiac sympathetic innervation with iodine-123-metaiodobenzylguanidine imaging in silent myocardial ischemia.
    Matsuo S; Takahashi M; Nakamura Y; Kinoshita M
    J Nucl Med; 1996 May; 37(5):712-7. PubMed ID: 8965132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of hypertensive hypertrophy in which both regression of hypertrophy and improvement of the abnormalities in iodine-123-metaiodobenzylguanidine (MIBG) myocardial imagings were observed after antihypertensive therapy].
    Morimoto S; Terada K; Keira N; Satoda M; Inoue K; Tatsukawa H; Katoh S; Sugihara H; Takeda K
    Kaku Igaku; 1995 Oct; 32(10):1107-12. PubMed ID: 8523833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine-123-metaiodobenzylguanidine myocardial imaging in patients with right ventricular pressure overload.
    Morimitsu T; Miyahara Y; Sinboku H; Ikeda S; Naito T; Nishijima K; Takao M
    J Nucl Med; 1996 Aug; 37(8):1343-6. PubMed ID: 8708768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantitative analysis of 123I-metaiodobenzylguanidine myocardial imaging: assessment of its usefulness in patients with congestive heart failure].
    Narita M; Kurihara T; Murano K; Usami M; Honda M
    Kaku Igaku; 1994 Apr; 31(4):347-58. PubMed ID: 8196231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial uptake of metaiodobenzylguanidine in patients with left ventricular hypertrophy secondary to valvular aortic stenosis.
    Fagret D; Wolf JE; Vanzetto G; Borrel E
    J Nucl Med; 1993 Jan; 34(1):57-60. PubMed ID: 8418271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of hypertrophic cardiomyopathy with 123I-metaiodobenzylguanidine].
    Nakajima K; Bunko H; Taki J; Shimizu M; Nanbu I; Muramori A; Matsunari I; Hisada K
    Kaku Igaku; 1990 Jan; 27(1):33-8. PubMed ID: 2338765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of norepinephrine content in the myocardium in hypertensive patients with left ventricular hypertrophy].
    Schwebel C; Fagret D; Tremel F; Siché JP; Boutelant S; de Gaudemaris R; Mallion JM
    Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1099-102. PubMed ID: 1482241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac iodine-123 metaiodobenzylguanidine uptake in animals with diabetes mellitus and/or hypertension.
    Dubois EA; Kam KL; Somsen GA; Boer GJ; de Bruin K; Batink HD; Pfaffendorf M; van Royen EA; van Zwieten PA
    Eur J Nucl Med; 1996 Aug; 23(8):901-8. PubMed ID: 8753678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of 123I-metaiodobenzylguanidine SPECT for detecting left ventricular involvement in patients with arrhythmogenic right ventricular dysplasia].
    Takahashi N; Ishida Y; Maeno M; Hirose Y; Kawano S; Fukuoka S; Hayashida K; Kuribayashi S; Hamada S; Yamada N; Takamiya M; Shimomura K; Ohe T
    Kaku Igaku; 1996 Jan; 33(1):57-67. PubMed ID: 8819715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myocardial imaging with 123I-metaiodobenzylguanidine (123I-MIBG) in essential hypertension: does the 123I-MIBG imaging have the ability to predict its prognosis?].
    Narita M; Kurihara T; Murano K; Usami M; Honda M
    Kaku Igaku; 1994 Aug; 31(8):879-89. PubMed ID: 7933677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myocardial ischemia and abnormality of cardiac sympathetic nervous function in apical hypertrophic cardiomyopathy].
    Taniguchi Y; Sugihara H; Terada K; Ito K; Ohtsuki K; Shiga K; Shima T; Nakamura T; Azuma A; Kohno Y
    J Cardiol; 1994; 24(4):293-8. PubMed ID: 8057241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of myocardial distribution of iodine-123 labeled metaiodobenzylguanidine (123I-MIBG) in normal subjects].
    Tsuchimochi S; Tamaki N; Shirakawa S; Fujita T; Yonekura Y; Konishi J; Nohara R; Sasayama S; Nishioka K
    Kaku Igaku; 1994 Mar; 31(3):257-64. PubMed ID: 8176864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of 123I-meta-iodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy.
    Nakajima K; Bunko H; Taki J; Shimizu M; Muramori A; Hisada K
    Am Heart J; 1990 Jun; 119(6):1329-37. PubMed ID: 2353619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.